28th Annual JPMorgan Healthcare Conference--Affymax and Infinity Pharmaceuticals.
The JP Morgan Healthcare Conference, held in San Francisco, included presentations by various pharmaceutical companies summarizing their achievements in 2009 and expectations for 2010. This conference report highlights presentations from Affymax Inc and Infinity Pharmaceuticals Inc. Investigational drugs from Affymax, including Hematide (in collaboration with Takeda Pharmaceutical Co Ltd), and from Infinity Pharmaceuticals, including IPI-926, retaspimycin hydrochloride, IPI-493 and IPI-940, are discussed.